Theodore L. Phillips

Theodore L. Phillips is Professor Emeritus of Radiation Oncology at the University of California, San Francisco, and one of the founding figures of stereotactic radiosurgery in North America. Over a career spanning more than four decades at UCSF, he played a pivotal role in establishing Gamma Knife radiosurgery as a clinical discipline, conducting foundational clinical and radiobiological studies that validated the safety and efficacy of single-fraction high-dose irradiation to intracranial targets. He collaborated extensively with Lars Leksell's group in Stockholm and was among the first American investigators to document the biological mechanisms underlying the precise tumor cell kill achieved with stereotactic techniques. Phillips made seminal contributions to the understanding of normal tissue radiation biology, particularly the dose-response relationships in lung, liver, kidney, and spinal cord. His work on radiation pneumonitis and hepatic radiotoxicity provided the experimental framework for modern organ-at-risk dose constraints used in stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT) planning. He also pioneered research into radiation sensitizers, including halogenated pyrimidines and hypoxic cell sensitizers such as misonidazole, conducting early-phase clinical trials that informed the rational design of combined chemoradiation regimens. Phillips served as Chair of the Department of Radiation Oncology at UCSF for many years and trained a generation of academic radiation oncologists who now lead programs across the United States. He was a founding member of the Radiation Therapy Oncology Group (RTOG) and contributed to numerous cooperative group protocols for brain tumors, lung cancer, and gastrointestinal malignancies. His lifetime contributions to the field earned him the ASTRO Gold Medal and honorary membership in numerous international radiation oncology societies.